<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sumya FT</submitter><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>733048</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8484713</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Conserved Oligomeric Golgi (COG) is an octameric protein complex that orchestrates intra-Golgi trafficking of glycosylation enzymes. Over a hundred individuals with 31 different COG mutations have been identified until now. The cellular phenotypes and clinical presentations of COG-CDGs are heterogeneous, and patients primarily represent neurological, skeletal, and hepatic abnormalities. The establishment of a cellular COG disease model will benefit the molecular study of the disease, explaining the detailed sequence of the interplay between the COG complex and the trafficking machinery. Moreover, patient fibroblasts are not a good representative of all the organ systems and cell types that are affected by COG mutations. We developed and characterized cellular models for human COG4 mutation</pubmed_abstract><journal>Frontiers in genetics</journal><pubmed_title>Development and Initial Characterization of Cellular Models for COG Complex-Related CDG-II Diseases.</pubmed_title><pmcid>PMC8484713</pmcid><funding_grant_id>R01 GM083144</funding_grant_id><funding_grant_id>Unassigned</funding_grant_id><pubmed_authors>Pokrovskaya ID</pubmed_authors><pubmed_authors>Lupashin V</pubmed_authors><pubmed_authors>Sumya FT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development and Initial Characterization of Cellular Models for COG Complex-Related CDG-II Diseases.</name><description>Conserved Oligomeric Golgi (COG) is an octameric protein complex that orchestrates intra-Golgi trafficking of glycosylation enzymes. Over a hundred individuals with 31 different COG mutations have been identified until now. The cellular phenotypes and clinical presentations of COG-CDGs are heterogeneous, and patients primarily represent neurological, skeletal, and hepatic abnormalities. The establishment of a cellular COG disease model will benefit the molecular study of the disease, explaining the detailed sequence of the interplay between the COG complex and the trafficking machinery. Moreover, patient fibroblasts are not a good representative of all the organ systems and cell types that are affected by COG mutations. We developed and characterized cellular models for human COG4 mutation</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-08T18:10:57.23Z</modification><creation>2022-02-11T11:49:17.028Z</creation></dates><accession>S-EPMC8484713</accession><cross_references><pubmed>34603392</pubmed><doi>10.3389/fgene.2021.733048</doi></cross_references></HashMap>